Specialty Medical Chairs Market was held at around US$ 3.3 Billion in 2023 and is expected to grow with a CAGR of 8.7% from 2023 to 2033. The growing geriatric population is expected to accelerate the demand for specialty medical chairs over the forecast period. The market is expected to account for an absolute dollar opportunity of nearly US$ 4.2 Billion from 2023 to 2033.
Attribute | Details |
---|---|
Global Specialty Medical Chairs Market (2023) | US$ 3.3 Billion |
Global Specialty Medical Chairs Market (2033) | US$ 7.5 Billion |
Global Specialty Medical Chairs Market CAGR (2023 to 2033) | 8.7% |
USA Specialty Medical Chairs Market CAGR (2023 to 2033) | 8.6% |
Key Companies Profiled |
|
Don't pay for what you don't need
Customize your report by selecting specific countries or regions and save 30%!
As per the Specialty Medical Chairs Market industry research by Future Market Insights - a market research and competitive intelligence provider, historically, from 2018 to 2022, the market increased at around 7.8% CAGR. The market is projected to grow at a CAGR of 8.7% over the coming ten years.
Individuals can use specialty medical chairs to improve their movement or comfort during certain surgical procedures. In hospitals, clinics, and ambulatory surgery centers, specialty medical chairs can be utilized during patient examinations and treatment. Furthermore, the versatility and manoeuvrability of specialty medical chairs enable experts to employ them in a variety of healthcare settings.
Demand for specialty medical chairs is being driven by rising awareness of medical issues and increased access to medical aid in different parts of the world. Furthermore, the industry is growing due to a growing preference for at-home healthcare. Furthermore, over the projection period, ongoing research and development activity by leading companies to develop innovative goods is expected to improve product sales.
In the near future, market players are projected to benefit from the introduction of technologically improved and fully automated medical chairs. The market is growing due to a surge in the number of hospitals and healthcare facilities.
Specialty medical chairs, such as dialysis chairs, rehabilitation chairs, and birthing chairs are in higher demand as the number of hospitals and clinics grows. As a result, the specialist medical chair market is growing at a faster rate.
According to an annual assessment of hospitals in the United States conducted by the American Hospital Association (AHA), there were 5,534 hospitals registered in the United States in 2018. Furthermore, increased government financing for the healthcare sector is boosting the market growth.
With a market share of over 40%, North America carries significant opportunities in the specialty medical chairs market, due to the region's growing senior population. Over the next 10 years, the regional market will be driven by the rising prevalence of lifestyle-related illnesses.
The demand is also being pushed by an increase in the number of dental, ophthalmology, and ENT clinics in the United States and Canada. Furthermore, the regional market's overall growth is aided by the existence of prominent competitors, improved healthcare infrastructure, as well as high disposable income levels, and significant lifestyle changes.
Due to an expanding aging population, Asia Pacific is expected to be the fastest-growing regional market over the assessment period. A significant increase in the senior population in the region is expected to diminish the workforce and raise public healthcare costs in this region, boosting the use of specialist medical chairs as a result.
Additionally, the presence of supportive international institutions such as the United Nations Population Fund, which assists developing nations in establishing and executing national strategies and policies, is expected to propel market growth. Furthermore, increased disposable income and ongoing research and development initiatives by leading regional companies to produce innovative medical chairs are projected to support market expansion in the future years.
In 2022, the market in the United States was worth US$ 1.2 billion, with a CAGR of 7.9% from 2018 to 2022. The growing number of dental clinics, ophthalmology, and ENT clinics across the country is driving the demand for specialist medical chairs. From 2023 to 2033, the US market for specialty medical chairs is expected to account for an absolute dollar opportunity of US$ 1.6 billion.
The market in the United Kingdom is expected to reach a valuation of US$ 398 Million by 2033. Growing with a CAGR of 8.9% in the forecast period, the market in the country is projected to garner an absolute dollar opportunity of around US$ 227 Million.
In Japan, the market is expected to grow at a CAGR of 10.8% from 2023 to 2033, reaching around US$ 275.9 Million by 2033. The market in the country is expected to gross an absolute dollar opportunity of US$ 176.6 Million during the forecast period.
The market in South Korea is expected to reach a valuation of around US$ 170.2 Million by 2033, growing at a CAGR of 10.4% from 2023 to 2033. The market in the country is expected to witness an absolute dollar opportunity of around US$ 106.7 Million.
Get the data you need at a Fraction of the cost
Personalize your report by choosing insights you need
and save 40%!
With a market share of 41%, rehabilitation chairs contribute significantly to the market. Bariatric, geriatric, and pediatric chairs are examples of rehabilitation chairs.
Activities such as bathing, positioning, and mobility are possible with pediatric chairs. Geriatric and bariatric chairs can perform similar roles, with the exception that the weight-bearing capability of these chairs may be larger. Over the next several years, the market is expected to be driven by a growing senior population and an increase in incidences of paralysis and spinal injuries.
According to WHO, studies done in Africa in 2018 revealed that between 62.5% and 82.5% of people in need of rehabilitation services do not obtain them, thus increasing their demand for rehabilitation services and related chairs.
During the projection period, sales of treatment chairs are expected to grow at a CAGR of 8%. They are an essential component of any therapy procedure, including operations.
One of the key advantages of these devices is that they assist patients in achieving a comfortable posture, which allows doctors full access to various body areas. This equipment improves patient relaxation while also increasing caregiver and patient safety. The market for treatment chairs is expected to grow steadily during the analysis period.
The key players operating in the Specialty Medical Chairs Market are A-dec, Inc., ActiveAid, Inc., DentalEZ, Inc., Fresenius Medical Care AG & Co. KGaA, Topcon Corp., Midmark Corp., Danaher, Dentsply Sirona, Planmeca Oy, and Hill Laboratories Company.
The global market size was estimated at US$ 3 Billion in 2022 and is expected to grow further to US$ 3.3 Billion in 2023.
The market value is projected to increase at a CAGR of around 8.7% from 2023 to 2033.
The market value increased at a CAGR of around 7.8% from 2018 to 2022.
The growing geriatric population is expected to accelerate the demand for specialty medical chairs over the forecast period.
The top 5 countries driving demand for the Specialty Medical Chairs Market are the United States, China, Japan, the UK, and South Korea.
United States accounted for over 40% of global Specialty Medical Chairs Market demand in 2022.
The market in the UK is projected to expand at a CAGR of around 8.9% from 2023 to 2033.
1. Executive Summary | Specialty Medical Chairs Market
1.1. Global Market Outlook
1.2. Demand-side Trends
1.3. Supply-side Trends
1.4. Technology Roadmap Analysis
1.5. Analysis and Recommendations
2. Market Overview
2.1. Market Coverage / Taxonomy
2.2. Market Definition / Scope / Limitations
3. Market Background
3.1. Market Dynamics
3.1.1. Drivers
3.1.2. Restraints
3.1.3. Opportunity
3.1.4. Trends
3.2. Scenario Forecast
3.2.1. Demand in Optimistic Scenario
3.2.2. Demand in Likely Scenario
3.2.3. Demand in Conservative Scenario
3.3. Opportunity Map Analysis
3.4. Investment Feasibility Matrix
3.5. PESTLE and Porter’s Analysis
3.6. Regulatory Landscape
3.6.1. By Key Regions
3.6.2. By Key Countries
3.7. Regional Parent Market Outlook
4. Global Market Analysis 2018 to 2022 and Forecast, 2023 to 2033
4.1. Historical Market Size Value (US$ Million) Analysis, 2018 to 2022
4.2. Current and Future Market Size Value (US$ Million) Projections, 2023 to 2033
4.2.1. Y-o-Y Growth Trend Analysis
4.2.2. Absolute $ Opportunity Analysis
5. Global Market Analysis 2018 to 2022 and Forecast 2023 to 2033, By Type
5.1. Introduction / Key Findings
5.2. Historical Market Size Value (US$ Million) Analysis By Type, 2018 to 2022
5.3. Current and Future Market Size Value (US$ Million) Analysis and Forecast By Type, 2023 to 2033
5.3.1. Examination
5.3.1.1. Birthing
5.3.1.2. Cardiac
5.3.1.3. Blood Drawing
5.3.1.4. Dialysis
5.3.1.5. Mammography
5.3.2. Treatment
5.3.2.1. Ophthalmic
5.3.2.2. ENT
5.3.2.3. Dental
5.3.2.4. Other Treatments
5.3.3. Rehabilitation
5.3.3.1. Paediatric
5.3.3.2. Bariatric
5.3.3.3. Geriatric
5.3.3.4. Other Rehabilitations
5.4. Y-o-Y Growth Trend Analysis By Type, 2018 to 2022
5.5. Absolute $ Opportunity Analysis By Type, 2023 to 2033
6. Global Market Analysis 2018 to 2022 and Forecast 2023 to 2033, By Region
6.1. Introduction
6.2. Historical Market Size Value (US$ Million) Analysis By Region, 2018 to 2022
6.3. Current Market Size Value (US$ Million) Analysis and Forecast By Region, 2023 to 2033
6.3.1. North America
6.3.2. Latin America
6.3.3. Europe
6.3.4. Asia Pacific
6.3.5. Middle East and Africa
6.4. Market Attractiveness Analysis By Region
7. North America Market Analysis 2018 to 2022 and Forecast 2023 to 2033, By Country
7.1. Historical Market Size Value (US$ Million) Trend Analysis By Market Taxonomy, 2018 to 2022
7.2. Market Size Value (US$ Million) Forecast By Market Taxonomy, 2023 to 2033
7.2.1. By Country
7.2.1.1. USA
7.2.1.2. Canada
7.2.2. By Type
7.3. Market Attractiveness Analysis
7.3.1. By Country
7.3.2. By Type
7.4. Key Takeaways
8. Latin America Market Analysis 2018 to 2022 and Forecast 2023 to 2033, By Country
8.1. Historical Market Size Value (US$ Million) Trend Analysis By Market Taxonomy, 2018 to 2022
8.2. Market Size Value (US$ Million) Forecast By Market Taxonomy, 2023 to 2033
8.2.1. By Country
8.2.1.1. Brazil
8.2.1.2. Mexico
8.2.1.3. Rest of Latin America
8.2.2. By Type
8.3. Market Attractiveness Analysis
8.3.1. By Country
8.3.2. By Type
8.4. Key Takeaways
9. Europe Market Analysis 2018 to 2022 and Forecast 2023 to 2033, By Country
9.1. Historical Market Size Value (US$ Million) Trend Analysis By Market Taxonomy, 2018 to 2022
9.2. Market Size Value (US$ Million) Forecast By Market Taxonomy, 2023 to 2033
9.2.1. By Country
9.2.1.1. Germany
9.2.1.2. United Kingdom
9.2.1.3. France
9.2.1.4. Spain
9.2.1.5. Italy
9.2.1.6. Russia
9.2.1.7. Rest of Europe
9.2.2. By Type
9.3. Market Attractiveness Analysis
9.3.1. By Country
9.3.2. By Type
9.4. Key Takeaways
10. Asia Pacific Market Analysis 2018 to 2022 and Forecast 2023 to 2033, By Country
10.1. Historical Market Size Value (US$ Million) Trend Analysis By Market Taxonomy, 2018 to 2022
10.2. Market Size Value (US$ Million) Forecast By Market Taxonomy, 2023 to 2033
10.2.1. By Country
10.2.1.1. China
10.2.1.2. Japan
10.2.1.3. India
10.2.1.4. South Korea
10.2.1.5. Australia
10.2.1.6. Rest of APAC
10.2.2. By Type
10.3. Market Attractiveness Analysis
10.3.1. By Country
10.3.2. By Type
10.4. Key Takeaways
11. Middle East and Africa Market Analysis 2018 to 2022 and Forecast 2023 to 2033, By Country
11.1. Historical Market Size Value (US$ Million) Trend Analysis By Market Taxonomy, 2018 to 2022
11.2. Market Size Value (US$ Million) Forecast By Market Taxonomy, 2023 to 2033
11.2.1. By Country
11.2.1.1. South Africa
11.2.1.2. Saudi Arabia
11.2.1.3. UAE
11.2.1.4. Israel
11.2.1.5. Rest of MEA
11.2.2. By Type
11.3. Market Attractiveness Analysis
11.3.1. By Country
11.3.2. By Type
11.4. Key Takeaways
12. Key Countries Market Analysis
12.1. USA
12.1.1. Pricing Analysis
12.1.2. Market Share Analysis, 2022
12.1.2.1. By Type
12.2. Canada
12.2.1. Pricing Analysis
12.2.2. Market Share Analysis, 2022
12.2.2.1. By Type
12.3. Brazil
12.3.1. Pricing Analysis
12.3.2. Market Share Analysis, 2022
12.3.2.1. By Type
12.4. Mexico
12.4.1. Pricing Analysis
12.4.2. Market Share Analysis, 2022
12.4.2.1. By Type
12.5. Germany
12.5.1. Pricing Analysis
12.5.2. Market Share Analysis, 2022
12.5.2.1. By Type
12.6. United Kingdom
12.6.1. Pricing Analysis
12.6.2. Market Share Analysis, 2022
12.6.2.1. By Type
12.7. France
12.7.1. Pricing Analysis
12.7.2. Market Share Analysis, 2022
12.7.2.1. By Type
12.8. Spain
12.8.1. Pricing Analysis
12.8.2. Market Share Analysis, 2022
12.8.2.1. By Type
12.9. Italy
12.9.1. Pricing Analysis
12.9.2. Market Share Analysis, 2022
12.9.2.1. By Type
12.10. Russia
12.10.1. Pricing Analysis
12.10.2. Market Share Analysis, 2022
12.10.2.1. By Type
12.11. China
12.11.1. Pricing Analysis
12.11.2. Market Share Analysis, 2022
12.11.2.1. By Type
12.12. Japan
12.12.1. Pricing Analysis
12.12.2. Market Share Analysis, 2022
12.12.2.1. By Type
12.13. India
12.13.1. Pricing Analysis
12.13.2. Market Share Analysis, 2022
12.13.2.1. By Type
12.14. South Korea
12.14.1. Pricing Analysis
12.14.2. Market Share Analysis, 2022
12.14.2.1. By Type
12.15. Australia
12.15.1. Pricing Analysis
12.15.2. Market Share Analysis, 2022
12.15.2.1. By Type
12.16. South Africa
12.16.1. Pricing Analysis
12.16.2. Market Share Analysis, 2022
12.16.2.1. By Type
12.17. Saudi Arabia
12.17.1. Pricing Analysis
12.17.2. Market Share Analysis, 2022
12.17.2.1. By Type
12.18. UAE
12.18.1. Pricing Analysis
12.18.2. Market Share Analysis, 2022
12.18.2.1. By Type
12.19. Israel
12.19.1. Pricing Analysis
12.19.2. Market Share Analysis, 2022
12.19.2.1. By Type
13. Market Structure Analysis
13.1. Competition Dashboard
13.2. Competition Benchmarking
13.3. Market Share Analysis of Top Players
13.3.1. By Regional
13.3.2. By Type
14. Competition Analysis
14.1. Competition Deep Dive
14.1.1. A-dec, Inc.
14.1.1.1. Overview
14.1.1.2. Product Portfolio
14.1.1.3. Profitability by Market Segments
14.1.1.4. Sales Footprint
14.1.1.5. Strategy Overview
14.1.1.5.1. Marketing Strategy
14.1.2. ActiveAid, Inc.
14.1.2.1. Overview
14.1.2.2. Product Portfolio
14.1.2.3. Profitability by Market Segments
14.1.2.4. Sales Footprint
14.1.2.5. Strategy Overview
14.1.2.5.1. Marketing Strategy
14.1.3. DentalEZ, Inc.
14.1.3.1. Overview
14.1.3.2. Product Portfolio
14.1.3.3. Profitability by Market Segments
14.1.3.4. Sales Footprint
14.1.3.5. Strategy Overview
14.1.3.5.1. Marketing Strategy
14.1.4. Fresenius Medical Care AG & Co. KGaA
14.1.4.1. Overview
14.1.4.2. Product Portfolio
14.1.4.3. Profitability by Market Segments
14.1.4.4. Sales Footprint
14.1.4.5. Strategy Overview
14.1.4.5.1. Marketing Strategy
14.1.5. Topcon Corp.
14.1.5.1. Overview
14.1.5.2. Product Portfolio
14.1.5.3. Profitability by Market Segments
14.1.5.4. Sales Footprint
14.1.5.5. Strategy Overview
14.1.5.5.1. Marketing Strategy
14.1.6. Midmark Corp.
14.1.6.1. Overview
14.1.6.2. Product Portfolio
14.1.6.3. Profitability by Market Segments
14.1.6.4. Sales Footprint
14.1.6.5. Strategy Overview
14.1.6.5.1. Marketing Strategy
14.1.7. Danaher
14.1.7.1. Overview
14.1.7.2. Product Portfolio
14.1.7.3. Profitability by Market Segments
14.1.7.4. Sales Footprint
14.1.7.5. Strategy Overview
14.1.7.5.1. Marketing Strategy
14.1.8. Dentsply Sirona
14.1.8.1. Overview
14.1.8.2. Product Portfolio
14.1.8.3. Profitability by Market Segments
14.1.8.4. Sales Footprint
14.1.8.5. Strategy Overview
14.1.8.5.1. Marketing Strategy
14.1.9. Planmeca Oy
14.1.9.1. Overview
14.1.9.2. Product Portfolio
14.1.9.3. Profitability by Market Segments
14.1.9.4. Sales Footprint
14.1.9.5. Strategy Overview
14.1.9.5.1. Marketing Strategy
14.1.10. Hill Laboratories Company
14.1.10.1. Overview
14.1.10.2. Product Portfolio
14.1.10.3. Profitability by Market Segments
14.1.10.4. Sales Footprint
14.1.10.5. Strategy Overview
14.1.10.5.1. Marketing Strategy
15. Assumptions & Acronyms Used
16. Research Methodology
Explore Healthcare Insights
View Reports